Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating | Investor's Business Daily TRENDING: SpaceX Isn't The Only Giant Eyeing An IPO On Thursday, Tarsus Pharmaceuticals (TARS) stock got an upgrade to its Relative Strength (RS) Rating, from 76 to 82. X Reading Between The Lines: How To Watch For Market Turns Through News Coverage See All Videos NOW PLAYING Reading Between The Lines: How To Watch For Market Turns Through News Coverage Looking For The Best Stocks To Buy And Watch? Start Here IBD's pr ...